Rifampicin-resistant tuberculosis in Iran: A systematic review and meta-analysis
Iran J Basic Med Sci
.
2021 Jun;24(6):720-725.
doi: 10.22038/ijbms.2021.47360.10901.
Authors
Farhad Bahraminia
1
,
Taher Azimi
2
,
Moein Zangiabadian
3
,
Mohammad Javad Nasiri
4
,
Mehdi Goudarzi
4
,
Masoud Dadashi
5
,
Abbas Ali Imani Fooladi
1
Affiliations
1
Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
2
Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
3
Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
4
Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
5
Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
PMID:
34630948
PMCID:
PMC8487596
DOI:
10.22038/ijbms.2021.47360.10901
No abstract available
Keywords:
Drug resistance; Iran; Rifampicin; Tuberculosis; Xpert MTB/RIF assay.
Publication types
Review